These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19140921)

  • 1. Drug therapy for atrial fibrillation: what will its role be in the era of increasing use of catheter ablation?
    Morrow JP; Reiffel JA
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):108-18. PubMed ID: 19140921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of atrial fibrillation therapy.
    Dorian P
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S11-6. PubMed ID: 16939433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical management of atrial fibrillation: state of the art.
    Camm J
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S2-6. PubMed ID: 16939435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation-the final frontier.
    Govindan M; Savelieva I; Catanchin A; Camm AJ
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):36S-50S. PubMed ID: 20940451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dronedarone: an emerging agent with rhythm- and rate-controlling effects.
    Wegener FT; Ehrlich JR; Hohnloser SH
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S17-20. PubMed ID: 16939434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging concepts on catheter ablation of atrial fibrillation from the tenth annual Boston Atrial Fibrillation Symposium.
    Keane D; Reddy V; Ruskin J;
    J Cardiovasc Electrophysiol; 2005 Sep; 16(9):1025-8. PubMed ID: 16174029
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological therapy following catheter ablation of atrial fibrillation.
    Rordorf R; Savastano S; Gandolfi E; Vicentini A; Petracci B; Landolina M
    J Cardiovasc Med (Hagerstown); 2012 Jan; 13(1):9-15. PubMed ID: 22025202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of rhythm and rate control in patients with atrial fibrillation.
    Prystowsky EN
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S7-10. PubMed ID: 16939436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality after catheter ablation for atrial fibrillation compared with antiarrhythmic drug therapy. A meta-analysis of randomized trials.
    Dagres N; Varounis C; Flevari P; Piorkowski C; Bode K; Rallidis LS; Tsougos E; Leftheriotis D; Sommer P; Hindricks G; Kremastinos DT
    Am Heart J; 2009 Jul; 158(1):15-20. PubMed ID: 19540387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year trends in the use of catheter ablation for treatment of atrial fibrillation vs. the use of coronary intervention for the treatment of ischaemic heart disease in Australia.
    Kumar S; Walters TE; Halloran K; Morton JB; Hepworth G; Wong CX; Kistler PM; Sanders P; Kalman JM
    Europace; 2013 Dec; 15(12):1702-9. PubMed ID: 23796617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What role for antiarrhythmic drugs today in patients with recurrent atrial fibrillation without relevant heart disease?].
    Alboni P
    G Ital Cardiol (Rome); 2015 Nov; 16(11):617-24. PubMed ID: 26571475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation: cure or treat?
    Forleo GB; Tondo C
    Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):187-96. PubMed ID: 19443515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of catheter ablation versus antiarrhythmic drug therapy for atrial fibrillation.
    Novak PG
    Curr Opin Cardiol; 2009 Jan; 24(1):9-17. PubMed ID: 19077814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Catheter ablation of atrial fibrillation in patients with structural heart disease: when to think about it?].
    Gaita F; Di Donna P; Caponi D; Scaglione M
    G Ital Cardiol (Rome); 2009 Sep; 10(9):572-9. PubMed ID: 19891249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation and the expanding role of catheter ablation: do antiarrhythmic drugs have a future?
    Naccarelli GV; Gonzalez MD
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):203-9. PubMed ID: 18806600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter ablation of atrial fibrillation in the elderly: where do we stand?
    Traub D; Daubert JP; McNitt S; Zareba W; Hall B
    Cardiol J; 2009; 16(2):113-20. PubMed ID: 19387957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic therapy following ablation of atrial fibrillation.
    Stabile G; Iuliano A; Agresta A; La Rocca V; D'Ascia S; De Simone A
    Expert Rev Cardiovasc Ther; 2013 Jul; 11(7):837-42. PubMed ID: 23895027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized evaluation of right atrial ablation after left atrial ablation of complex fractionated atrial electrograms for long-lasting persistent atrial fibrillation.
    Oral H; Chugh A; Good E; Crawford T; Sarrazin JF; Kuhne M; Chalfoun N; Wells D; Boonyapisit W; Gadeela N; Sankaran S; Kfahagi A; Jongnarangsin K; Pelosi F; Bogun F; Morady F
    Circ Arrhythm Electrophysiol; 2008 Apr; 1(1):6-13. PubMed ID: 19808388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioversion for atrial fibrillation: treatment options and advances.
    Reiffel JA
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):1073-84. PubMed ID: 19659629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New antiarrhythmic drugs for prevention of atrial fibrillation.
    Goldstein RN; Stambler BS
    Prog Cardiovasc Dis; 2005; 48(3):193-208. PubMed ID: 16271945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.